BP-1003

N/A

Report date: 2024/04/23 17:57:42
NME

Base Information

Drug NameBP-1003
Drug Alias NameLiposomal Stat-3BP-1003BP1003
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsRNA interference
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsSolid tumoursLung NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesBio-Path Holdings IncThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsOvarian Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A